Clinical Trial

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Recruiting
View on ClinicalTrials.gov →
Summary
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-05-06.
Trial Details
NCT Number NCT04880356
Lead Sponsor Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions Inherited Disease, Rare Diseases, Metabolic Disease, Undiagnosed Disease, Neurologic Disorder, Neuro-Degenerative Disease
Enrollment 100 participants
Start Date 2021-03-01
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2024-11-19